Berry Genomics Co Ltd (000710) — Cash Flow-to-Debt Ratio
Berry Genomics Co Ltd (000710) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-2.18 Million could theoretically repay 0% of its total liabilities (CN¥694.43 Million) in one year. See 000710 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Berry Genomics Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Berry Genomics Co Ltd across 27 annual periods. Also explore Berry Genomics Co Ltd (000710) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Berry Genomics Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Berry Genomics Co Ltd. For market capitalisation and broader financial context, see 000710 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥87.97 Million | CN¥669.56 Million | ▲ +0.2% |
| 2023 | 0.13x | CN¥111.01 Million | CN¥846.56 Million | ▲ +439.6% |
| 2022 | 0.02x | CN¥21.18 Million | CN¥871.54 Million | ▼ -74.3% |
| 2021 | 0.09x | CN¥94.03 Million | CN¥996.02 Million | ▼ -51.9% |
| 2020 | 0.20x | CN¥161.31 Million | CN¥821.52 Million | ▲ +15.2% |
| 2019 | 0.17x | CN¥123.06 Million | CN¥721.83 Million | ▼ -75.7% |
| 2018 | 0.70x | CN¥165.33 Million | CN¥235.68 Million | ▲ +132.0% |
| 2017 | 0.30x | CN¥74.35 Million | CN¥245.94 Million | ▲ +1024.5% |
| 2016 | -0.03x | CN¥-14.19 Million | CN¥433.97 Million | ▲ +82.4% |
| 2015 | -0.19x | CN¥-70.81 Million | CN¥381.19 Million | ▼ -410.2% |
| 2014 | 0.06x | CN¥18.91 Million | CN¥315.83 Million | ▲ +10.8% |
| 2013 | 0.05x | CN¥15.63 Million | CN¥289.09 Million | ▼ -75.7% |
| 2012 | 0.22x | CN¥48.27 Million | CN¥217.34 Million | ▲ +340.9% |
| 2011 | -0.09x | CN¥-21.46 Million | CN¥232.73 Million | ▼ -131.6% |
| 2010 | 0.29x | CN¥76.19 Million | CN¥261.04 Million | ▲ +3252.5% |
| 2009 | -0.01x | CN¥-2.33 Million | CN¥251.54 Million | ▼ -103.3% |
| 2008 | 0.28x | CN¥57.76 Million | CN¥206.93 Million | ▲ +680.6% |
| 2007 | 0.04x | CN¥4.70 Million | CN¥131.54 Million | ▼ -55.6% |
| 2006 | 0.08x | CN¥11.68 Million | CN¥144.87 Million | ▲ +43.8% |
| 2005 | 0.06x | CN¥7.58 Million | CN¥135.26 Million | ▲ +244.6% |
| 2004 | -0.04x | CN¥-6.43 Million | CN¥165.77 Million | ▼ -361.6% |
| 2003 | -0.01x | CN¥-1.23 Million | CN¥146.30 Million | ▼ -107.5% |
| 2002 | 0.11x | CN¥14.91 Million | CN¥133.22 Million | ▲ +125.7% |
| 2001 | -0.44x | CN¥-85.39 Million | CN¥195.81 Million | ▼ -565.4% |
| 2000 | -0.07x | CN¥-8.21 Million | CN¥125.33 Million | ▼ -133.3% |
| 1999 | 0.20x | CN¥15.30 Million | CN¥77.77 Million | ▼ -33.0% |
| 1998 | 0.29x | CN¥28.30 Million | CN¥96.34 Million | — |